REPAIR - Phase 1 trial of Pidnarulex and Talazoparib in Patients with Metastatic Castration Resistant Prostate Cancer

  • Voskoboynik, Mark (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description


StatusActive
Effective start/end date7/12/22 → 12/09/25

Keywords

  • Clinical trial
  • castrate resistant prostate cancer
  • Chemotherapy
  • Talazoparib